Similar articles

• Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis.

  Roux S, Seelig HP, Meyer O. Roux S, et al. J Rheumatol. 1998 Feb;25(2):395-6. J Rheumatol. 1998. PMID: 9489847 No abstract available.
• [Laboratory diagnostics of polymyositis/dermatomyositis].

  Prus V, Bedeković D. Prus V, et al. Reumatizam. 2012;59(2):27-30. Reumatizam. 2012. PMID: 23745451 Croatian.
• [Pulmonary lesion in polymyositis and dermatomyositis].

  Bondarenko IB, Mukhin NA, Nasonov EL, Kornev BM, Shtutman VZ, Guseva NG. Bondarenko IB, et al. Klin Med (Mosk). 1998;76(2):20-4. Klin Med (Mosk). 1998. PMID: 9553354 Review. Russian. No abstract available.
• [Clinical and pathological investigation of polymyositis and dermatomyositis: report of 83 cases].

  Li Q, Lu BX, Zhou L, An SL. Li Q, et al. Di Yi Jun Yi Da Xue Xue Bao. 2002 Dec;22(12):1139-40. Di Yi Jun Yi Da Xue Xue Bao. 2002. PMID: 12480599 Chinese.
• Polymyositis and dermatomyositis: pathophysiology.

  Nagaraju K, Lundberg IE. Nagaraju K, et al. Rheum Dis Clin North Am. 2011 May;37(2):159-71, v. doi: 10.1016/j.rdc.2011.01.002. Rheum Dis Clin North Am. 2011. PMID: 21444017 Review.